| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell, Tumor, and Stem Cell Biology |
1 Burnham Institute for Medical Research, La Jolla, California and 2 Center for Comparative Medicine and Pathology Department, University of California, Davis, Davis, California
Requests for reprints: Barbara Ranscht, Burnham Institute for Medical Research, 10901 North Torrey Pines Road, La Jolla, CA 92037. Phone: 858-646-3122 or 858-646-3100, ext. 3243; Fax: 858-646-3197; E-mail: ranscht{at}burnham.org.
Key Words: T-cadherin vasculature mammary tumor
T-cadherin delineates endothelial, myoepithelial, and ductal epithelial cells in the normal mouse mammary gland, and becomes progressively restricted to the vasculature during mammary tumorigenesis. To test the function of T-cadherin in breast cancer, we inactivated the T-cadherin (Cdh13) gene in mice and evaluated tumor development and pathology after crossing the mutation into the mouse mammary tumor virus (MMTV)-polyoma virus middle T (PyV-mT) transgenic model. We report that T-cadherin deficiency limits mammary tumor vascularization and reduces tumor growth. Tumor transplantation experiments confirm the stromal role of T-cadherin in tumorigenesis. In comparison with wild-type MMTV-PyV-mT controls, T-cadherin–deficient tumors are pathologically advanced and metastasize to the lungs. T-cadherin is a suggested binding partner for high molecular weight forms of the circulating, fat-secreted hormone adiponectin. We discern adiponectin in association with the T-cadherin–positive vasculature in the normal and malignant mammary glands and report that this interaction is lost in the T-cadherin null condition. This work establishes a role for T-cadherin in promoting tumor angiogenesis and raises the possibility that vascular T-cadherin-adiponectin association may contribute to the molecular cross-talk between tumor cells and the stromal compartment in breast cancer. [Cancer Res 2008;68(5):1407–16]
This article has been cited by other articles:
![]() |
M. B. Joshi, E. Kyriakakis, D. Pfaff, K. Rupp, M. Philippova, P. Erne, and T. J. Resink Extracellular cadherin repeat domains EC1 and EC5 of T-cadherin are essential for its ability to stimulate angiogenic behavior of endothelial cells FASEB J, November 1, 2009; 23(11): 4011 - 4021. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Andreeva, M. A. Kutuzov, V. A. Tkachuk, and T. A. Voyno-Yasenetskaya T-cadherin is located in the nucleus and centrosomes in endothelial cells Am J Physiol Cell Physiol, November 1, 2009; 297(5): C1168 - C1177. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Org, S. Eyheramendy, P. Juhanson, C. Gieger, P. Lichtner, N. Klopp, G. Veldre, A. Doring, M. Viigimaa, S. Sober, et al. Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations Hum. Mol. Genet., June 15, 2009; 18(12): 2288 - 2296. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Landskroner-Eiger, B. Qian, E. S. Muise, A. R. Nawrocki, J. P. Berger, E. J. Fine, W. Koba, Y. Deng, J. W. Pollard, and P. E. Scherer Proangiogenic Contribution of Adiponectin toward Mammary Tumor Growth In vivo Clin. Cancer Res., May 15, 2009; 15(10): 3265 - 3276. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Denzel, L. W. Hebbard, G. Shostak, L. Shapiro, R. D. Cardiff, and B. Ranscht Adiponectin Deficiency Limits Tumor Vascularization in the MMTV-PyV-mT Mouse Model of Mammary Cancer Clin. Cancer Res., May 15, 2009; 15(10): 3256 - 3264. [Abstract] [Full Text] [PDF] |
||||
![]() |
Correction: T-cadherin Regulates Angiogenesis Cancer Res., April 15, 2008; 68(8): 3076 - 3076. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |